| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 14.832 | 617.395 | 264.079 | 1.974.794 |
| Total Income - EUR | - | - | - | - | - | - | 14.832 | 617.407 | 264.123 | 2.375.374 |
| Total Expenses - EUR | - | - | - | - | - | - | 14.680 | 438.775 | 233.950 | 2.037.934 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 152 | 178.631 | 30.173 | 337.440 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -293 | 174.184 | 27.664 | 292.237 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Tetra Med Inspire S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 760 | 1.075 | 2.319 | 21.182 |
| Current Assets | - | - | - | - | - | - | 113.970 | 458.824 | 267.827 | 787.161 |
| Inventories | - | - | - | - | - | - | 80.319 | 227 | 2.739 | 16.548 |
| Receivables | - | - | - | - | - | - | 11.066 | 330.906 | 232.118 | 614.176 |
| Cash | - | - | - | - | - | - | 22.585 | 127.691 | 32.969 | 156.437 |
| Shareholders Funds | - | - | - | - | - | - | -252 | 173.931 | 27.712 | 292.285 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 114.982 | 286.124 | 242.906 | 517.874 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Tetra Med Inspire S.r.l.